MIAMI, Dec. 13, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink sheets:GLSN) today announced that it has retained Hogan & Hartson LLP in connection with obtaining necessary approvals for Medicaid and other reimbursement programs in all 50 states for its Nutraplete Therapeutic Drink Mix. Nutraplete is the first therapeutic dietary supplement designed specifically for people living with HIV/AIDS. Nutraplete is manufactured and distributed through BioSource Therapeutics, Inc. a Galea Life Sciences, Inc. subsidiary.
About Hogan & Hartson
Hogan & Hartson is an international law firm headquartered in Washington, D.C. with over 1,000 attorneys practicing in offices around the globe. The firm's broad-based international practice cuts across virtually all legal disciplines and industries.
Hogan & Hartson has offices in Baltimore, Beijing, Berlin, Boulder, Brussels, Budapest, Caracas, Colorado Springs, Denver, Geneva, Hong Kong, London, Los Angeles, Miami, Moscow, Munich, New York, Northern Virginia, Paris, Shanghai, Tokyo, Warsaw, and Washington, D.C.
For more information about the firm, visit ww.hhlaw.com
About Nutraplete
Nutraplete is the first therapeutic dietary supplement designed specifically for people living with HIV/AIDS. It is a multi-nutritional supplement, designed to address AIDS Wasting Syndrome. It works in conjunction with antiviral therapies and assists patients in the adherence and tolerance of treatments. Nutraplete is a "functional food" that encourages the restoration of lean body mass, can inhibit pro-oxidative stress, and improve immune function. Nutraplete is available by prescription, and has started the application process for inclusion with Medicaid and AIDS Drugs Assistance Program (ADAP) formularies. Nutraplete is distributed nationally by Allion Healthcare, Inc. (NASDAQ: ALLI) under its MOMS Pharmacy trade name. www.momspharmacy.com
For more information: www.nutraplete.com
About Galea Life Sciences, Inc.
Galea Life Sciences, Inc. (Pink Sheets:GLSN) is currently a non-reporting, over-the-counter, publicly traded company. GLSN identifies and acquires new and innovative nutraceutical product and dietary supplement companies with outstanding growth potential. GLSN's focus is in the emerging scientific field of advanced nutritional supplements designed to support traditional medical treatments and therapies. BioSource Therapeutics, Inc. (BST), a GLSN subsidiary, is an entrepreneurial life sciences company. BST specializes in the formulation, manufacturing, marketing and distribution of innovative dietary supplements that benefit people undergoing medical treatments and therapies.